Cargando…
Thrombosis and myocardial infarction: the role of bioresorbable scaffolds
Coronary atherosclerosis is a leading cause of death as a result of coronary thrombosis and acute myocardial infarction. Drug-eluting stents (DES) have dramatically improved the treatment of coronary artery stenosis. However, stent thrombosis (ST) and in-stent-restenosis (ISR) have remained a vexing...
Autores principales: | Leesar, Massoud A., Feldman, Marc D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288217/ https://www.ncbi.nlm.nih.gov/pubmed/37362388 http://dx.doi.org/10.20517/jca.2022.41 |
Ejemplares similares
-
One-year efficacy and safety of everolimus-eluting bioresorbable scaffolds in the setting of acute myocardial infarction
por: Kim, Yongcheol, et al.
Publicado: (2020) -
A Case of Subacute Bioresorbable Vascular Scaffold Thrombosis, What was Wrong?
por: Abualnaja, Seraj A., et al.
Publicado: (2017) -
Coronary Aneurysm Formation After Bioresorbable Vascular Scaffold Implantation Resulting in Acute Myocardial Infarction
por: Fang, Ching-Chang, et al.
Publicado: (2017) -
“The Unpredictable ABSORB” – Very Late Stent Thrombosis of Bioresorbable Vascular Scaffold
por: Pradhan, Akshyaya, et al.
Publicado: (2019) -
Jailing polymer jacketed guide-wires during bifurcation coronary interventions is associated with procedural myocardial infarction
por: Chatterjee, Arka, et al.
Publicado: (2017)